-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E6pMkqeGFwKu9QnqwMs4TzMlndGh+fREwzHEW1I8GvPyPcacswqccTydo1ADzAcl WK4QuVJjTfQBZo969wD7cQ== 0001127602-09-016352.txt : 20090729 0001127602-09-016352.hdr.sgml : 20090729 20090729164040 ACCESSION NUMBER: 0001127602-09-016352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090727 FILED AS OF DATE: 20090729 DATE AS OF CHANGE: 20090729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONGIORNO THOMAS F CENTRAL INDEX KEY: 0001222675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 09970644 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-07-27 0001022079 QUEST DIAGNOSTICS INC DGX 0001222675 BONGIORNO THOMAS F C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 VP and Corporate Controller Common Stock 2009-07-27 4 M 0 3000 17.5781 A 13768 D Common Stock 2009-07-27 4 S 0 3000 56.0026 D 10768 D Common Stock 2939 I 401k Common Stock 2200 I By Ira Stock Options (Right to Buy) 17.5781 2009-07-27 4 M 0 3000 0 D 2003-06-26 2010-06-26 Common Stock 3000 0 D This transaction was executed in multiple trades at prices ranging from $56.00 to $56.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Thomas F. Bongiorno 2009-07-28 -----END PRIVACY-ENHANCED MESSAGE-----